Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Enhanced photodynamic performance of violet phosphorus nanosheets via covalent polyethylene-glycol modification for bacterial-infection therapy.

Created on 19 Nov 2026

Authors

Hao Wang, Yuxiang Gao, Kai Su, Jing Kang, Xiaodong Song, Alideertu Dong

Published in

Soft matter. Nov 18, 2026. Epub Nov 18, 2026.

Abstract

Bacterial infections within the wound microenvironment and the exacerbation of antimicrobial resistance (AMR) present significant challenges to skin tissue regeneration. Endowed with a "nano-knife" effect and photodynamic therapy (PDT) potential, violet phosphorus nanosheets (VPNS) have emerged as promising non-antibiotic antibacterial materials. However, their inherently poor colloidal stability severely limits their biomedical applications. To overcome this bottleneck, we functionalized VPNS with a diazonium-terminated polyethylene glycol (HO-PEG-AD) via the formation of stable C-P covalent bonds, successfully constructing VPNS@PEG-AD nanocomposites. This modification significantly enhances the stable dispersion time in aqueous solutions and subsequently improves the efficiency of reactive oxygen species (ROS) generation under light irradiation. In vitro assays demonstrated that VPNS@PEG-AD exhibits a potent synergistic antibacterial effect against both Escherichia coli and Staphylococcus aureus upon irradiation, driven by the dual action of physical piercing and ROS-mediated oxidative damage. Furthermore, in a murine model of S. aureus-infected epidermal wounds, the VPNS@PEG-AD effectively eradicated infection, suppressed inflammatory cell infiltration, and significantly accelerated wound healing without exhibiting obvious systemic toxicity. In summary, this highly stable PEGylated VPNS nanoplatform provides a safe and highly efficient strategy for combating AMR and promoting the healing of infected wounds.

PMID:
43050289
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement